Health Care [ 8/12 ] | Health Care Providers & Services [ 44/75 ]
NASDAQ | Common Stock
Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States.
The company offers Optejet, a topical ophthalmic medication dispensing platform services.
It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi; and agreement with Formosa Pharmaceuticals.
Inc. for Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in theU. S.
The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025.
Hyperion DeFi, Inc. was founded in 2014 and is based in New York, New York.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 11, 25 | 0.05 Increased by +100.62% | -6.40 Increased by +100.85% |
| Aug 11, 25 | -2.50 Decreased by -1.09 K% | -7.20 Increased by +65.31% |
| Apr 15, 25 | -3.69 Decreased by -1.50 K% | -8.00 Increased by +53.88% |
| Mar 26, 25 | -16.44 Decreased by -9.03 K% | -0.09 Decreased by -18.17 K% |
| Nov 12, 24 | -8.80 Decreased by -4.79 K% | -8.00 Decreased by -10.00% |
| Aug 12, 24 | -0.21 Decreased by -31.25% | -0.15 Decreased by -40.00% |
| May 15, 24 | -0.23 Decreased by -53.33% | -0.23 |
| Mar 18, 24 | -0.18 Decreased by -5.88% | -0.17 Decreased by -5.88% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 25 | 302.51 K Increased by +18.52 K% | 6.63 M Increased by +184.00% | Increased by +2.19 K% Increased by +100.45% |
| Jun 30, 25 | 0.00 Decreased by -100.00% | -8.69 M Increased by +21.38% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 14.72 K Increased by +194.81% | -3.48 M Increased by +68.11% | Decreased by -23.67 K% Increased by +89.18% |
| Dec 31, 24 | 28.09 K Increased by +985.09% | -19.95 M Decreased by -150.46% | Decreased by -71.03 K% Increased by +76.92% |
| Sep 30, 24 | 1.63 K - | -7.89 M - | Decreased by -485.41 K% - |
| Jun 30, 24 | 22.63 K - | -11.05 M - | Decreased by -48.86 K% - |
| Mar 31, 24 | 4.99 K - | -10.92 M - | Decreased by -218.75 K% - |
| Dec 31, 23 | 2.59 K - | -7.97 M - | Decreased by -307.73 K% - |